Biogen (BIIB) Q1 Earnings Beat, Stock Up on Alzheimer Drug Uptake
ZacksBiogen’s (BIIB) first-quarter earnings beat estimates but sales miss the mark. While sales of key drugs like Tecfidera, Tysabri & Spinraza declined, the company’s cost-saving efforts show promise.